Actinium Pharmaceuticals, Inc. ATNM Balance Sheet

Actinium pharmaceuticals, inc. (ATNM)

Balance Sheet / TTM

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Dec'10
Assets
Current Assets:
Cash and cash equivalents
9,253	14,312	19,520	9,924	13,673	14,805	21,474	26,763	17,399	20,541	11,456	17,087	20,519	15,527	20,455	22,206	25,643	24,762	25,952	19,284	6,706	11,750	14,670	-	5,533	3,990	5,650	3,239	-	-	-	-	-	-	-	-
Restricted cash - current
48	48	88	-	40	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restricted cash - current
-	-	-	40	-	40	40	40	-	0	0	0	34	34	34	34	34	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5,877	-	-	-	-	5,618	0	0	0	5,703	0	0	0
R&D reimbursement receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	237	-	-	-
Prepaid expenses and other current assets
785	189	336	299	616	311	570	843	439	672	1,009	1,031	1,836	1,558	922	937	803	157	257	634	699	671	608	667	218	53	84	117	167	-	-	-	5	-	-	-
Deferred financing costs, net of accumulated amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	252	-	-	-
Deposits on hand
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-
Inventory
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-
Total Current Assets
10,087	14,550	19,945	10,264	14,329	15,156	22,084	27,647	17,838	21,214	12,465	18,119	22,390	17,120	21,412	23,178	26,481	24,919	26,209	19,919	7,406	12,422	15,278	6,545	5,751	4,043	5,734	3,357	5,785	0	0	0	6,199	0	0	0
Property and equipment, net of accumulated depreciation of $237,417 and $266,381
113	121	134	140	118	104	59	52	57	65	70	75	88	91	109	115	106	95	86	101	127	141	132	14	13	6	0	0	3	-	-	0	1	-	-	0
Operating lease right-of-use assets
807	963	1,035	1,107	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Finance leases right-of-use assets
221	241	261	282	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Security deposit
49	49	49	49	49	49	49	49	49	49	49	49	49	49	49	49	0	-	-	-	-	34	34	-	-	-	-	-	-	-	-	-	-	-	-	-
Restricted cash
391	391	391	391	391	390	390	-	390	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restricted cash
-	-	-	-	-	-	-	390	-	390	390	-	0	-	-	-	-	34	34	34	34	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-
Equipment and parts
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	0
(Less) Accumulated depreciation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	0
Total Non current assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	0
Total Assets
11,670	16,317	21,818	12,235	14,889	15,702	22,584	28,140	18,337	21,721	12,976	18,244	22,528	17,261	21,572	23,344	26,587	25,049	26,330	20,055	7,569	12,598	15,446	6,559	5,765	4,049	5,734	3,357	5,788	0	0	0	6,200	0	0	0
Liabilities and Stockholders' Equity
Current Liabilities:
Accounts payable and accrued expenses
4,597	5,130	4,700	5,317	5,814	4,122	5,266	6,386	4,650	3,450	3,604	4,768	4,194	2,570	1,379	1,852	1,473	888	1,011	1,248	2,283	1,731	1,045	615	378	-	-	-	-	-	-	-	-	-	-	-
Accounts payable and accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	312	793	459	897	-	-	-	644	-	-	-
Accounts payable and accrued expenses - related parties
-	-	-	-	-	-	-	-	-	25	75	25	25	25	85	25	25	38	25	307	214	278	189	189	81	375	31	31	31	-	-	-	0	-	-	-
Note payable
380	25	100	175	249	-	-	-	-	-	-	-	-	0	89	178	265	0	92	189	283	0	54	94	157	0	36	74	140	-	-	-	0	-	-	-
Operating leases current liability
286	307	301	287	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Finance leases current liability
78	77	75	74	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Convertible notes payable, net of unamortized discount
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	124	-	-	-
Derivative liabilities
-	-	-	-	-	0	0	6	15	54	426	576	300	431	934	1,230	2,848	1,228	1,922	1,864	6,709	8,216	9,826	19,128	6,707	2,757	2,957	2,240	3,574	-	-	-	4,439	-	-	-
Accounts Payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	1	0	13
Accounts Payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-
Accrued Legal Fees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	0	1	-	1	0	1
Accrued interest (Balance Sheet)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	30	28	27	-	-	-	21
State corporate tax payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-
State corporate tax payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Accrued interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	24	23	-
Total Current Liabilities
5,343	5,540	5,178	5,854	6,063	4,122	5,266	6,393	4,666	3,529	4,106	5,369	4,520	3,027	2,488	3,285	4,613	2,155	3,050	3,610	9,491	10,226	11,116	20,028	7,325	3,445	3,819	2,806	4,643	31	29	29	5,208	28	24	36
Long-term operating lease obligations
531	669	749	826	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Long-term finance lease obligations
150	171	191	210	13	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Notes payable related parties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	72	71	64	-	-	-	58
Notes payable related parties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	53	53	-
Total Liabilities
6,025	6,381	6,118	6,892	6,076	4,122	5,266	6,393	4,666	3,529	4,106	5,369	4,520	3,027	2,488	3,285	4,613	2,155	3,050	3,610	9,491	10,226	11,116	-	7,325	3,445	3,819	-	4,643	103	100	94	-	81	78	94
Commitments and contingencies
-	-	-	-	-	0	-	0	-	0	0	0	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	0	-	-	-
Stockholders' Equity:
Preferred stock, $0.001 par value; 50,000,000 shares authorized, 0 shares issued and outstanding
-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common stock, $0.001 par value; 1,000,000,000 and 600,000,000 shares authorized; 164,701,167 and 115,703,044 shares issued and outstanding
164	164	162	119	115	110	110	110	80	80	58	57	55	47	47	44	44	41	40	35	29	29	27	25	24	236	235	213	21	111	111	111	136	111	111	111
Additional paid-in capital
214,237	213,926	213,094	197,751	195,554	192,007	191,597	191,104	176,744	176,101	160,479	157,431	154,504	144,042	142,294	136,646	134,160	128,542	124,982	110,688	89,252	88,120	84,004	69,723	64,933	61,005	60,895	56,769	56,867	63	63	63	48,237	63	63	63
Accumulated deficit
-208,757	-204,155	-197,555	-192,527	-186,857	-180,537	-174,389	-169,467	-163,153	-157,989	-151,667	-144,613	-136,551	-129,856	-123,257	-116,633	-112,230	-105,689	-101,743	-94,279	-91,204	-85,778	-797,016	-	-66,517	-	-	-	-	-279	-275	-269	-	-257	-253	-270
Deficit accumulated during the development stage
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	83,216	-	60,637	59,216	56,432	55,743	-	-	-	47,382	-	-	-
Total Stockholders' Equity
5,644	9,935	15,700	5,342	8,812	11,580	17,318	21,747	13,671	18,192	8,870	12,875	18,008	14,234	19,084	20,058	21,974	22,894	23,279	16,444	-1,922	2,371	4,329	-13,468	-1,559	604	1,914	550	1,145	-103	-100	-93	992	-81	-78	-94
Total Liabilities and Stockholders' Equity
11,670	16,317	21,818	12,235	14,889	15,702	22,584	28,140	18,337	21,721	12,976	18,244	22,528	17,261	21,572	23,344	26,587	25,049	26,330	20,055	7,569	12,598	15,446	6,559	5,765	4,049	5,734	3,357	5,788	0	0	0	6,200	0	0	0